InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Alles Mark J, Director. Officer active across 2 companies, notably Turning Point Therapeutics, Inc.. Aggregated, 5 filings have been logged. Total volume traded: €273k. The latest transaction was filed on 24 May 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations5 total
04,980 shares0
Common Stock
SEC:0001567619-22-011784:0·
02,300 shares0
Common Stock
SEC:0001567619-22-000661·
02,300 shares0
Common Stock
SEC:0001567619-22-000661:0·
€136,5622,000 shares@ €68.2809100.0% of flow
Common Stock
SEC:0001209191-21-042325·
Ideal exit: 18 Mar 2022 (T+270)
€136,5622,000 shares@ €68.280950.0% of flow
Common Stock
SEC:0001209191-21-042325:0·
Ideal exit: 18 Mar 2022 (T+270)
5 of 5 declarations
About Alles Mark J
Mark J. Alles is a Director at Turning Point Therapeutics, Inc. and BioMarin Pharmaceutical Inc. He plays a key role in the governance and strategy of these companies. Turning Point Therapeutics is a biopharmaceutical company focused on developing treatments for cancer. Mark brings valuable expertise in the field, contributing to the direction and growth of the companies.
